Pharmaceuticals News

ALBANY, N.Y., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), sebuah organisasi pembangunan dan pengilangan kontrak (CDMO) terkemuka di peringkat global, hari ini mengumumkan pelaburan...

ALBANY, Nova York, Oct. 05, 2026 (GLOBE NEWSWIRE) -- A Curia Global, Inc. (Curia), uma organização líder global de desenvolvimento e fabricação por contrato (CDMO), anunciou hoje um investimento...

ALBANY, Nueva York, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), una organización líder mundial en desarrollo y fabricación por contrato (CDMO), anunció hoy una inversión...

ออลบานี รัฐนิวยอร์ก, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia) องค์กรชั้นนำระดับโลกด้านการวิจัย พัฒนา และรับจ้างผลิต (Contract, Development and Manufacturing Organization: CDMO)...

Pistol and Paris Launches Vanquish Medical Providing Access and Serving Medical Cannabis Patients Across Canada

-24-Month Crossover Analysis: Patients Starting Deramiocel After a Year on Placebo Slowed Upper Limb Decline by 76% Compared with Their Own Prior Year- -At 24 Months, Both Groups Showed Slower...

Raleigh-Durham, North Carolina; King of Prussia, Pennsylvania, USA; Bern, Switzerland, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Kymanox®, a leading global life sciences consulting and professional services...

The Phase 1/2 ABILITY-1 Clinical Trial is evaluating MDNA11 in expansion cohorts comprised of patients with advanced and metastatic gastrointestinal, endometrial, and melanoma cancers Selected as one...

Freya Biosciences named as one of Fierce Biotech’s “Fierce 15” for 2026, designating it as one of the most innovative and promising private biotechs

LONDON and CAMBRIDGE, Mass., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Beacon Therapeutics, a leading clinical-stage biotechnology company with a mission to save and restore vision in people with rare and...